AbbVie Inc (ABBV) — Cash Flow-to-Debt Ratio
AbbVie Inc (ABBV) has a Cash Flow-to-Debt Ratio of 0.04x as of December 2025, meaning its operating cash flow of $5.22 Billion could theoretically repay 0% of its total liabilities ($137.19 Billion) in one year. See ABBV free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
AbbVie Inc Cash Flow-to-Debt Ratio (2010–2025)
Historical debt coverage capacity for AbbVie Inc across 16 annual periods. Also explore AbbVie Inc net asset momentum to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for AbbVie Inc (2010–2025)
Year-by-year debt coverage analysis for AbbVie Inc. For market capitalisation and broader financial context, see AbbVie Inc market cap and net worth.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.14x | $19.03 Billion | $137.19 Billion | ▼ -2.8% |
| 2024 | 0.14x | $18.81 Billion | $131.80 Billion | ▼ -22.3% |
| 2023 | 0.18x | $22.84 Billion | $124.31 Billion | ▼ -10.5% |
| 2022 | 0.21x | $24.94 Billion | $121.52 Billion | ▲ +18.1% |
| 2021 | 0.17x | $22.78 Billion | $131.09 Billion | ▲ +35.8% |
| 2020 | 0.13x | $17.59 Billion | $137.47 Billion | ▼ -6.6% |
| 2019 | 0.14x | $13.32 Billion | $97.29 Billion | ▼ -30.8% |
| 2018 | 0.20x | $13.43 Billion | $67.80 Billion | ▲ +30.6% |
| 2017 | 0.15x | $9.96 Billion | $65.69 Billion | ▲ +32.4% |
| 2016 | 0.11x | $7.04 Billion | $61.46 Billion | ▼ -25.3% |
| 2015 | 0.15x | $7.54 Billion | $49.10 Billion | ▲ +11.4% |
| 2014 | 0.14x | $3.55 Billion | $25.77 Billion | ▼ -45.7% |
| 2013 | 0.25x | $6.27 Billion | $24.71 Billion | ▼ -5.5% |
| 2012 | 0.27x | $6.34 Billion | $23.64 Billion | ▼ -67.4% |
| 2011 | 0.82x | $6.25 Billion | $7.59 Billion | ▼ -10.1% |
| 2010 | 0.92x | $4.98 Billion | $5.43 Billion | — |